Designer Estrogen May Offer Safer Alternative to Hormone Therapy (IMAGE)
Caption
A structural model of the estrogen receptor ERα bound to synthetic estrogen (PaPE-1) in comparison to natural estrogen (estradiol E2). This material relates to a paper that appeared in the May 24, 2016, issue of Science Signaling, published by AAAS. The paper, by Z. Madak-Erdogan at University of Illinois at Urbana-Champaign in Urbana, IL, and colleagues was titled, 'Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues.'
Credit
Z. Madak-Erdogan <i>et al. / Science Signaling</i> (2016)
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content